Damnacanthal, a noni anthraquinone, inhibits c-Met and is a potent antitumor compound against Hep G2 human hepatocellular carcinoma cells
Javier A. Garcia‐Vilas(Instituto de Investigación Biomédica de Málaga), Miguel Ángel Medina(Centre for Biomedical Network Research on Rare Diseases)
Cited by 50
Related Papers
Fasentin diminishes endothelial cell proliferation, differentiation and invasion in a glucose metabolism-independent manner
|Scientific Reports|2020|39
Glucose Favors Lipid Anabolic Metabolism in the Invasive Breast Cancer Cell Line MDA-MB-231
|Biology|2020|22
What is known on angiogenesis‐related rare diseases? A systematic review of literature
|Journal of Cellular and Molecular Medicine|2012|20
Highly Glycolytic Immortalized Human Dermal Microvascular Endothelial Cells are Able to Grow in Glucose-Starved Conditions
|Biomolecules|2019|10
(+)-Aeroplysinin-1 Modulates the Redox Balance of Endothelial Cells
|Marine Drugs|2018|8